Latest papers

Multiple myeloma presenting with hepatosplenomegaly.

Renal improvement in myeloma with bortezomib plus plasma exchange.

Ocular manifestations of multiple myeloma: three cases and a review of the literature.

Multiple myeloma.

The novel JAK inhibitor AZD1480 blocks STAT3 and FGFR3 signaling, resulting in suppression of human myeloma cell growth and survival.

Inflammation driven by tumour-specific Th1 cells protects against B-cell cancer.

Physical activity and hematologic cancer prevention.

Genomics in multiple myeloma research.

Thromboembolism with immunomodulatory agents in the treatment of multiple myeloma.

Physical activity and hematological cancer survivorship.

A rare pancreatic pseudoaneurysm in patient with acute pancreatitis and multiple myeloma.

[Bilateral pleurisy revealing a myelome with free light chains complicated with an osseous amylose].

Induction of cellular immune responses in patients with stage-I multiple myeloma after vaccination with autologous idiotype-pulsed dendritic cells.

Thalidomide induced nonspecific interstitial pneumonia in patient with relapsed multiple myeloma.

Multiple myeloma: Implementing signaling pathways and molecular biology in clinical trials.

Stroke after treatment with bortezomib and dexamethasone in a Chinese patient with extramedullary relapse of multiple myeloma.

Benzene and human health: A historical review and appraisal of associations with various diseases

Management options for cast nephropathy in multiple myeloma.

Multiple myeloma unveiled by multiple hyperkeratotic spicules.

[Two autopsy cases with systemic amyloidosis--case 11/2010].